Conference abstract · 18 Aug 2016
Research articlePublished 2016
Insight into the Mutation-Induced Decrease of the Enzymatic Activity of Human Cytochrome P450 1A2
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As an important member of CYP1 sub-family, CYP1A2 mediates the metabolisms of approximately 5-10% of the currently clinical medicines, and plays a predominant role in the activation of precarcinogens. F186L mutation in this CYP enzyme is found to have ability to reduce the enzymatic activity. As this mutation is far away from the active site and has no influence on the protein expression, the detailed mechanism for F186L-induced the decrease of the enzymatic activity of CYP1A2 is still unknown. In the current study, we employed molecular dynamics simulation and free energy calculation to study the wild-type and F186L mutant CYP1A2 with a α-naphthoflavone (ANF) bound in the active site. Our simulations showed that instead of changing the backbone structure, the F186L mutation has significant impact on the side-chain conformations, resulting in a smaller active site and larger solvent accessible surface. The former could weaken the binding affinity of ANF in the active site, making the substrate far away from the active site so as to reduce the enzymatic activity. The latter could keep the substrate access channel in a closed state in most case, which was not propitious for the substrate entering into the active site by the substrate access channel. Our findings can reveal an in-depth understanding for the mechanism of the mutation-induced decrease of the enzymatic activity of human CYP1A2, providing useful information on the structure-function relationships of human CYP enzymes.
Keywords
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Oct 2013
An appropriate in vitro cocktail assay to simultaneously determine nine human cytochrome P450 activities using LC-MS/MS: Evaluation of Rosiglitazone for CYP2C8 probe substrate
Article · 30 Sep 2024
Biotransformation of Anti-Cancer Drugs: Role of Cytochrome P450 Enzymes
Article · 30 Sep 2024
Non-Cytochrome P450 Enzymes in Drug Metabolism: Emerging Roles
Review article · 2018
1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bei-Li Ying”
- BylineArticles whose byline prints “Bo-Tao Fa”
- BylineArticles whose byline prints “Shan Cong”
- BylineArticles whose byline prints “Yang Zhong”
- BylineArticles whose byline prints “Jing-Fang Wang”

